Abbonarsi

IRRITABLE BOWEL SYNDROME - 06/09/11

Doi : 10.1016/S0025-7125(05)70285-6 
Robin D. Rothstein, MD *

Riassunto

Irritable bowel syndrome (IBS) is the most common functional disorder of the gastrointestinal tract. As a result of the lack of specific diagnostic testing and absence of circumscribed biologic markers of disease, the diagnosis is based on a constellation of symptoms. In an attempt to standardize the definition of disease, an international consensus group formalized clinical parameters based on data from Manning et al40 for a symptom-based diagnosis. In reference to the location of the meeting, these criterion have been termed the Rome criteria and subsequently have been refined further (see the accompanying box).59 At present, because of incomplete understanding of the pathophysiology of IBS, patient subsets are defined by their predominant symptom (Figure 1).


Rome Criteria of Irritable Bowel Syndrome

Continuous or recurrent symptoms of:
Abdominal pain or discomfort that is relieved with defecation
Abdominal pain or discomfort that is associated with a change in frequency or stool
Abdominal pain or discomfort that is associated with a change in consistency of stool
Two or more of the following, for at least a quarter of occasions or days:
Altered stool frequency (>3 bowel movements per day or <3 bowel movements per week)
Altered stool form (lumpy/hard or loose/watery stool)
Passage of mucus
Bloating or feeling of abdominal distension

Symptoms of IBS have afflicted humans since antiquity. Maimonides advised that humans should strive to have their intestines relaxed all the days of their lives. IBS is a common disorder affecting approximately 15% of the population.1 One third seek medical attention from their primary physician, and 10% to 15% are referred to a gastroenterologist.47 Based on the large portion of the population affected, the societal costs of the disease are immense. Physician visits total approximately 3.5 million a year, and medications are prescribed for most patients, averaging 2.2 million prescriptions a year.19, 23 In a comparative study in 1992 dollars, office-based costs averaged $742 per IBS patient compared with $429 for nonpatients.57 Pharmacologic costs are significantly greater in IBS patients.14 Patients with IBS have a greater likelihood of suffering other medical and gastrointestinal problems.43 For example, functional dyspepsia occurs in more than one third of IBS sufferers.56 Patients with IBS are more likely to undergo surgery, including hysterectomies and appendectomies, and are more apt to have had multiple operations.38 Evaluation and treatment of associated disorders and the greater tendency for additional surgery inflate health care costs further.

Indirect costs are more difficult to calculate but appear substantial. In one study, absenteeism over 1 year averaged 13.4 days for patients with IBS compared with 4.0 days for controls. The diagnosis and treatment of IBS and its associated problems account for billions of health care dollars.

Il testo completo di questo articolo è disponibile in PDF.

Mappa


 Address reprint requests to Robin D. Rothstein, MD, Division of Gastroenterology, Pennsylvania Hospital, University of Pennsylvania Health System, Spruce Building, 9th Floor, 8th and Spruce Streets, Philadelphia, PA 19107


© 2000  W. B. Saunders Company. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 84 - N° 5

P. 1247-1257 - settembre 2000 Ritorno al numero
Articolo precedente Articolo precedente
  • CONSTIPATION
  • Arnold Wald
| Articolo seguente Articolo seguente
  • DIARRHEA
  • Lawrence R. Schiller

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.